236 related articles for article (PubMed ID: 28435038)
21. Combination of amino acid/dipeptide with ligustrazine-betulinic acid as antitumor agents.
Xu B; Yan WQ; Xu X; Wu GR; Zhang CZ; Han YT; Chu FH; Zhao R; Wang PL; Lei HM
Eur J Med Chem; 2017 Apr; 130():26-38. PubMed ID: 28237794
[TBL] [Abstract][Full Text] [Related]
22. Synthetic modification of hydroxychavicol by Mannich reaction and alkyne-azide cycloaddition derivatives depicting cytotoxic potential.
Kumar S; Pathania AS; Satti NK; Dutt P; Sharma N; Mallik FA; Ali A
Eur J Med Chem; 2015 Mar; 92():236-45. PubMed ID: 25559204
[TBL] [Abstract][Full Text] [Related]
23. Anticancer activity of 3-O-acylated betulinic acid derivatives obtained by enzymatic synthesis.
Ahmad FB; Ghaffari Moghaddam M; Basri M; Abdul Rahman MB
Biosci Biotechnol Biochem; 2010; 74(5):1025-9. PubMed ID: 20460723
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of betulinic acid derivatives with activity against human melanoma.
Kim DS; Pezzuto JM; Pisha E
Bioorg Med Chem Lett; 1998 Jul; 8(13):1707-12. PubMed ID: 9873420
[TBL] [Abstract][Full Text] [Related]
25. Betulinic Acid-Nitrogen Heterocyclic Derivatives: Design, Synthesis, and Antitumor Evaluation
Yang Y; Xie T; Tian X; Han N; Liu X; Chen H; Qi J; Gao F; Li W; Wu Q; Huo S; Gu Y; Dai Z; Wang P; Lei H
Molecules; 2020 Feb; 25(4):. PubMed ID: 32093264
[TBL] [Abstract][Full Text] [Related]
26. Solvent effect on copper-catalyzed azide-alkyne cycloaddition (CuAAC): synthesis of novel triazolyl substituted quinolines as potential anticancer agents.
Ellanki AR; Islam A; Rama VS; Pulipati RP; Rambabu D; Krishna GR; Reddy CM; Mukkanti K; Vanaja GR; Kalle AM; Kumar KS; Pal M
Bioorg Med Chem Lett; 2012 May; 22(10):3455-9. PubMed ID: 22516283
[TBL] [Abstract][Full Text] [Related]
27. Design and Synthesis of NO-releasing Betulinic Acid Derivatives as Potential Anticancer Agents.
Liu J; Zhu Z; Tang J; Lin Q; Chen L; Sun J
Anticancer Agents Med Chem; 2017; 17(2):241-249. PubMed ID: 27671295
[TBL] [Abstract][Full Text] [Related]
28. A 3D QSAR study of betulinic acid derivatives as anti-tumor agents using topomer CoMFA: model building studies and experimental verification.
Ding W; Sun M; Luo S; Xu T; Cao Y; Yan X; Wang Y
Molecules; 2013 Aug; 18(9):10228-41. PubMed ID: 23973995
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and cytotoxic activity of heterocyclic ring-substituted betulinic acid derivatives.
Kumar V; Rani N; Aggarwal P; Sanna VK; Singh AT; Jaggi M; Joshi N; Sharma PK; Irchhaiya R; Burman AC
Bioorg Med Chem Lett; 2008 Sep; 18(18):5058-62. PubMed ID: 18752941
[TBL] [Abstract][Full Text] [Related]
30. A convergent synthesis of alkyne-azide cycloaddition derivatives of 4-α,β-2-propyne podophyllotoxin depicting potent cytotoxic activity.
Zilla MK; Nayak D; Vishwakarma RA; Sharma PR; Goswami A; Ali A
Eur J Med Chem; 2014 Apr; 77():47-55. PubMed ID: 24607588
[TBL] [Abstract][Full Text] [Related]
31. 6-(4'-Aryl-1',2',3'-triazolyl)-spirostan-3,5-diols and 6-(4'-Aryl-1',2',3'-triazolyl)-7-hydroxyspirosta-1,4-dien-3-ones: Synthesis and analysis of their cytotoxicity.
Mironov ME; Oleshko OS; Pokrovskii MA; Rybalova TV; Pechurov VK; Pokrovskii AG; Cheresis SV; Mishinov SV; Stupak VV; Shults EE
Steroids; 2019 Nov; 151():108460. PubMed ID: 31344410
[TBL] [Abstract][Full Text] [Related]
32. Simple structural modifications confer cytotoxicity to allobetulin.
Heller L; Obernauer A; Csuk R
Bioorg Med Chem; 2015 Jul; 23(13):3002-12. PubMed ID: 26007303
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis, and anti-tumor activity of novel betulinic acid derivatives.
Liu JH; Tang J; Zhu ZF; Chen L
J Asian Nat Prod Res; 2014 Jan; 16(1):34-42. PubMed ID: 24350921
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of novel benzylidene analogues of betulinic acid as potent cytotoxic agents.
Gupta N; Rath SK; Singh J; Qayum A; Singh S; Sangwan PL
Eur J Med Chem; 2017 Jul; 135():517-530. PubMed ID: 28500966
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and cytotoxic activity of 17-carboxylic acid modified 23-hydroxy betulinic acid ester derivatives.
Bi Y; Xu J; Wu X; Ye W; Yuan S; Zhang L
Bioorg Med Chem Lett; 2007 Mar; 17(5):1475-8. PubMed ID: 17275295
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and anticancer activity of novel aza-artemisinin derivatives.
Jana S; Iram S; Thomas J; Liekens S; Dehaen W
Bioorg Med Chem; 2017 Jul; 25(14):3671-3676. PubMed ID: 28529044
[TBL] [Abstract][Full Text] [Related]
37. Betulinic acid derived hydroxamates and betulin derived carbamates are interesting scaffolds for the synthesis of novel cytotoxic compounds.
Wiemann J; Heller L; Perl V; Kluge R; Ströhl D; Csuk R
Eur J Med Chem; 2015 Dec; 106():194-210. PubMed ID: 26547057
[TBL] [Abstract][Full Text] [Related]
38. Design, Synthesis and Biological Evaluation of Betulinic Acid Derivatives as New Antitumor Agents for Leukemia.
Waechter F; da Silva GNS; Willig JB; de Oliveira CB; Vieira BD; Trivella DBB; Zimmer AR; Buffon A; Pilger DA; Gnoatto SCB
Anticancer Agents Med Chem; 2017; 17(13):1777-1785. PubMed ID: 28403779
[TBL] [Abstract][Full Text] [Related]
39. Mitochondria-Targeted Lupane Triterpenoid Derivatives and Their Selective Apoptosis-Inducing Anticancer Mechanisms.
Ye Y; Zhang T; Yuan H; Li D; Lou H; Fan P
J Med Chem; 2017 Jul; 60(14):6353-6363. PubMed ID: 28671831
[TBL] [Abstract][Full Text] [Related]
40. Development of C-20 modified betulinic acid derivatives as antitumor agents.
Kim JY; Koo HM; Kim DS
Bioorg Med Chem Lett; 2001 Sep; 11(17):2405-8. PubMed ID: 11527742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
